Antibody detailed product information

Code No. M061-3
Anti-Selenium Binding Protein mAb
Size 100 µL (1 mg/mL)
Availability (in Japan) 10 or more
（In Japan at 17:33, Aug 7, 2026 in JST）
Clonality Monoclonal
Clone 4D4
Isotype
(Immunized Animal) 		Mouse IgG1
Applications WB　1 µg/mL  
IH　2 µg/mL  
Immunogen
(Antigen)		 Recombinant full length Human SBP
Reactivity [Gene ID]

Human[8991], Mouse(w)[20341], Rat[140927]
Storage buffer 1 mg/mL in PBS/50% glycerol, pH 7.2
Storage temp. -20°C
Conjugate Unlabeled
Manufacturer MBL
Alternative names SELENBP1, selenium binding protein 1, LPSB, SP56, hSBP, SBP56, 56 kDa selenium-binding protein/Lp56, SBP56/Selenbp2
Product category Research area:Cancer
Data

Citations

Western Blotting

  1. Chen G et al. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol. 202, 321-9 (2004)(PMID:14991897)
  2. Huang KC et al. Selenium binding protein 1 in ovarian cancer. Int J Cancer 118, 2433-40 (2006)(PMID:16380993)
  3. Kim H et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6, 3466-76 (2006)(PMID:16645984)
  4. Stammer K et al. Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol. 109, 115-21 (2008)(PMID:18272210)
  5. Li T et al. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res. 52, 1289-99 (2008)(PMID:18435490)
  6. Silvers AL et al. Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res 16, 2009-21 (2010)(PMID:20332323)
  7. Zhang S et al. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium. PLoS One 8, e63702 (2013)(PMID:23704933)
  8. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol.20, 489-495 (2019)(PMID:30469030)
  9. Zhang XY et al. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition. Am J Transl Res. 10, 3567-3578 (2018) (PMID:30662608)
  10. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol. 20 489-495 (2019)(PMID:30469030)

Immunocytochemistry

  1. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol.20, 489-495 (2019)(PMID:30469030)
  2. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol. 20 489-495 (2019)(PMID:30469030)

Immunohistochemistry

  1. Chen G et al. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol. 202, 321-9 (2004)(PMID:14991897)
  2. Glatt SJ et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. PNAS 102, 15533-8 (2005)(PMID:16223876)
  3. Huang KC et al. Selenium binding protein 1 in ovarian cancer. Int J Cancer 118, 2433-40 (2006)(PMID:16380993)
  4. Kim H et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6, 3466-76 (2006)(PMID:16645984)
  5. Stammer K et al. Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol. 109, 115-21 (2008)(PMID:18272210)
  6. Li T et al. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res. 52, 1289-99 (2008)(PMID:18435490)
  7. Zhang C et al. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum Pathol. 41, 255-61 (2010)(PMID:19896693)
  8. Silvers AL et al. Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res 16, 2009-21 (2010)(PMID:20332323)
  9. Raucci R et al. Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. Biochim Biophys Acta 1814, 513-22 (2011)(PMID:21338716)
  10. Zhang XY et al. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition. Am J Transl Res. 10, 3567-3578 (2018)(PMID:30662608)
  • The availability is based on the information in Japan at 17:33, Aug 7, 2026 in JST.
  • The special price is shown in red color.
  • Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
  • Abbreviations for applications：
    WB: Western Blotting, IH: Immunohistochemistry, IC: Immunocytochemistry, IP: Immunoprecipitation
    FCM: Flow Cytometry, NT: Neutralization, IF: Immunofluorescence, RIP: RNP Immunoprecipitation
    ChIP: Chromatin Immunoprecipitation, CoIP: Co-Immunoprecipitation
    DB: Dot Blotting, NB: Northern Blotting, RNA FISH: RNA Fluorescence in situ hybridization
  • For applications and reactivity:
    *: The use is reported in a research article (Not tested by MBL). Please check the data sheet for detailed information.
    **: The use is reported from the licenser (Under evaluation or not tested by MBL).
  • For storage temparature: RT: room temparature
  • Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.
MBLCopyright (C)2015 Medical ＆ Biological Laboratories Co., Ltd. All Rights Reserve